Literature DB >> 9235136

[An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].

E Lupulescu, E Ioniţă, D Botez, M Matepciuc, M E Tabra, C Tecu, V Alexandrescu, A Munţiu.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9235136

Source DB:  PubMed          Journal:  Bacteriol Virusol Parazitol Epidemiol        ISSN： 1220-3696


× No keyword cloud information.
  2 in total

1.  Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.

Authors:  James D Allen; Satyajit Ray; Ted M Ross
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

2.  Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.

Authors:  Theone C Kon; Adrian Onu; Laurentiu Berbecila; Emilia Lupulescu; Alina Ghiorgisor; Gideon F Kersten; Yi-Qing Cui; Jean-Pierre Amorij; Leo Van der Pol
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.